Table 2 Summary of immunohistochemical analyses of the initial study (Study A, No. 1–7).
Case No. | Case | Age | TDP-43 | Aβ | Tau | Tau (neuronal/glial) | α-syn | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hip-Ent | Amygdala | Temporal | Frontal | Hip-Ent | Amygdala | Temporal | ||||||
1 | GRN mutation | 54 | FTLD-TDP (Type A) | A | IV | +++/+ | ++/+ | +/+ | +/+ | ++ | + | + |
2 | 56 | 0 | IV | +++/++ | +++/++ | +++/++ | ++/++ | + | N.A. | + | ||
3 | 72 | C | V | +++/+ | ++/+ | +++/++ | +++/- | N.A. | + | + | ||
4 | 55 | A | IV | +++/+ | +/+ | +/+ | +/+ | +++ | + | ++ | ||
5 | Control | 73 | Negative | B | IV | ++/− | ++/+ | ++/+ | N.A. | + | + | − |
6 | 76 | A | I | +/− | +/− | +/− | N.A. | + | + | − | ||
7 | 79 | A | I | ++/− | +/+ | +/+ | N.A. | + | + | − | ||
